Fairvoy Private Wealth LLC Invests $995,000 in Doximity, Inc. (NASDAQ:DOCS)

Fairvoy Private Wealth LLC purchased a new stake in shares of Doximity, Inc. (NASDAQ:DOCS) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 18,630 shares of the company’s stock, valued at approximately $995,000.

A number of other large investors have also added to or reduced their stakes in DOCS. UMB Bank n.a. lifted its stake in Doximity by 69.1% in the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after purchasing an additional 235 shares during the last quarter. Farther Finance Advisors LLC lifted its position in shares of Doximity by 324.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after buying an additional 603 shares during the last quarter. Morse Asset Management Inc bought a new position in shares of Doximity during the 3rd quarter worth $46,000. GAMMA Investing LLC increased its holdings in Doximity by 40.1% in the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after acquiring an additional 412 shares during the last quarter. Finally, Covestor Ltd increased its holdings in Doximity by 441.9% in the 3rd quarter. Covestor Ltd now owns 1,680 shares of the company’s stock worth $73,000 after acquiring an additional 1,370 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Stock Up 0.7 %

DOCS opened at $58.58 on Friday. The business’s fifty day simple moving average is $55.09 and its 200 day simple moving average is $45.31. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $61.75. The stock has a market cap of $10.94 billion, a PE ratio of 64.94, a P/E/G ratio of 4.68 and a beta of 1.39.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.02). The firm had revenue of $136.83 million for the quarter, compared to the consensus estimate of $127.05 million. Doximity had a net margin of 33.69% and a return on equity of 19.79%. During the same quarter last year, the company posted $0.18 earnings per share. As a group, equities analysts anticipate that Doximity, Inc. will post 0.88 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 37.40% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. Bank of America increased their target price on shares of Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. Mizuho started coverage on shares of Doximity in a report on Wednesday, December 4th. They issued a “neutral” rating and a $55.00 price objective for the company. Barclays boosted their target price on shares of Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a report on Monday, November 11th. JPMorgan Chase & Co. raised their price target on Doximity from $30.00 to $48.00 and gave the stock a “neutral” rating in a report on Thursday, November 21st. Finally, The Goldman Sachs Group initiated coverage on Doximity in a research note on Friday, November 15th. They set a “neutral” rating and a $58.00 price objective on the stock. Thirteen equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $53.12.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.